Seres Therapeutics
IPOEstablishing a Better Microbiome for Better Health
Public · Cambridge, United States · Founded 2010 · $154.5M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2010
- Business Model
- B2B
- Website
- serestherapeutics.com
- Total Funding
- $154.5M
- Last Round
- $134.0M Venture RoundJun 2015
- Rounds
- 3
- Type
- Public
About
Seres Therapeutics is a commercial-stage biotechnology company developing microbiome therapeutics. VOWST received FDA approval April 2023 for C. difficile recurrence prevention. Nestlé Health Science partnership.
Summary
Seres Therapeutics is a Biotech company based in Cambridge, United States, founded in 2010. It has raised $154.5M in total across 3 rounds, most recently a $134.0M Venture Round round in Jun 2015. Investors include Nestlé Health Science, ARCH Venture Partners and New Enterprise Associates.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2015
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...